prikaz prve stranice dokumenta Usage and Safety of Direct Oral Anticoagulants at Patients with Atrial Fibrillation and Planned Diagnostic Procedures, Interventions, and Surgery
  Preuzmi
PDF 377.54 KB
Znanstveni rad - Pregledni rad
Usage and Safety of Direct Oral Anticoagulants at Patients with Atrial Fibrillation and Planned Diagnostic Procedures, Interventions, and Surgery
Heart and Mind, 3 (2019), 1; 1-6. https://doi.org/10.4103/hm.hm_61_19
Mornar Jelavić, Marko; Krstačić, Goran; Pintarić, Hrvoje

Citiranost:
,
Citirajte ovaj rad

Mornar Jelavić, M., Krstačić, G. i Pintarić, H. (2019). Usage and Safety of Direct Oral Anticoagulants at Patients with Atrial Fibrillation and Planned Diagnostic Procedures, Interventions, and Surgery. Heart and Mind, 3. (1), 1-6. doi: 10.4103/hm.hm_61_19

Mornar Jelavić, Marko, et al. "Usage and Safety of Direct Oral Anticoagulants at Patients with Atrial Fibrillation and Planned Diagnostic Procedures, Interventions, and Surgery." Heart and Mind, vol. 3, br. 1, 2019, str. 1-6. https://doi.org/10.4103/hm.hm_61_19

Mornar Jelavić, Marko, Goran Krstačić i Hrvoje Pintarić. "Usage and Safety of Direct Oral Anticoagulants at Patients with Atrial Fibrillation and Planned Diagnostic Procedures, Interventions, and Surgery." Heart and Mind 3, br. 1 (2019): 1-6. https://doi.org/10.4103/hm.hm_61_19

Mornar Jelavić, M., Krstačić, G. i Pintarić, H. (2019) 'Usage and Safety of Direct Oral Anticoagulants at Patients with Atrial Fibrillation and Planned Diagnostic Procedures, Interventions, and Surgery', Heart and Mind, 3(1), str. 1-6. doi: 10.4103/hm.hm_61_19

Mornar Jelavić M, Krstačić G, Pintarić H. Usage and Safety of Direct Oral Anticoagulants at Patients with Atrial Fibrillation and Planned Diagnostic Procedures, Interventions, and Surgery. Heart and Mind [Internet]. 2019. [pristupljeno 28.02.2025.];3(1):1-6. doi: 10.4103/hm.hm_61_19

M. Mornar Jelavić, G. Krstačić i H. Pintarić, "Usage and Safety of Direct Oral Anticoagulants at Patients with Atrial Fibrillation and Planned Diagnostic Procedures, Interventions, and Surgery", Heart and Mind, vol. 3, br. 1, str. 1-6, 2019. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:127:885761. [Citirano: 28.02.2025.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:127:885761
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Usage and Safety of Direct Oral Anticoagulants at Patients with Atrial Fibrillation and Planned Diagnostic Procedures, Interventions, and Surgery
AutorMarko Mornar Jelavić
AutorGoran Krstačić
AutorHrvoje Pintarić
Autorova ustanova(Klinički bolnički centar Sestre milosrdnice)
Autorova ustanovaSveučilište Josipa Jurja Strossmayera u Osijeku
Fakultet za dentalnu medicinu i zdravstvo Osijek
Autorova ustanovaSveučilište u Zagrebu
Stomatološki fakultet
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Sažetak (engleski)
Atrial fibrillation (AF) affects about 2% of the population, with the increasing prevalence with age. It is associated with poorer quality of life, effort intolerance, frequent hospitalizations, heart failure, and increased risk of systemic embolization, stroke, and mortality. Warfarin has been the only choice of chronic anticoagulant therapy for over 50 years. Its disadvantages are reflected by interaction with various foods, drugs, and alcohol, while its action is highly dependent on liver... Više function, age, and genetic background. Administration of direct oral anticoagulants (DOACs) to patients with AF and acceptable bleeding risk reduces the risk of systemic thromboembolic complications and stroke; these drugs are superior or at least as effective as warfarin. Their use is safer than warfarin in terms of reduced risk of major bleeding. This is a group of drugs with wide clinical use, except in patients with severely impaired renal and hepatic function. Proper use is a guarantee of the safety of DOACs, which in the future will be even more pronounced with the advent of new antidotes, such as Praxbind. Sakrij dio sažetka
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Pregledni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran - međunarodna recenzija
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaHeart and Mind
Brojčani podacivol. 3, br. 1, str. 1-6
p-ISSN2468-6476
e-ISSN2468-6484
DOIhttps://doi.org/10.4103/hm.hm_61_19
URN:NBNurn:nbn:hr:127:885761
Datum objave publikacije2019
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje-Nekomercijalno-Dijeli pod istim uvjetima 4.0 međunarodna (CC BY-NC-SA 4.0)
Datum i vrijeme pohrane2024-02-09 12:09:11
accessibility

closePristupačnostrefresh

Ako želite spremiti trajne postavke, kliknite Spremi, ako ne - vaše će se postavke poništiti kad zatvorite preglednik.